Approval · Notice of Compliance 13126 · 2012
METADOL: Notice of Compliance 13126
Issued March 19, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13126
- Date
- March 19, 2012
- Company
- Paladin Labs Inc
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New tablet formulation
- Therapeutic class
- Opioid Analgesic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| METADOL | Not yet assigned | — |
Medicinal ingredients
- METHADONE HYDROCHLORIDE 1 MG per TAB
- METHADONE HYDROCHLORIDE 5 MG per TAB
- METHADONE HYDROCHLORIDE 10 MG per TAB
- METHADONE HYDROCHLORIDE 25 MG per TAB